Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

835 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Use of Japanese Traditional (Kampo) Medicines Before and During Pregnancy in Japan: The Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study.
Noda A, Arita R, Obara T, Suzuki S, Ohsawa M, Obara R, Morishita K, Ueno F, Matsuzaki F, Shinoda G, Murakami K, Orui M, Ishikuro M, Kikuchi A, Takayama S, Ishii T, Kuriyama S. Noda A, et al. Among authors: morishita k. Pharmacoepidemiol Drug Saf. 2024 Oct;33(10):e70033. doi: 10.1002/pds.70033. Pharmacoepidemiol Drug Saf. 2024. PMID: 39385718
Risk of Major Congenital Malformations Associated with the Use of Japanese Traditional (Kampo) Medicine Containing Ephedra During the First Trimester of Pregnancy.
Noda A, Obara T, Matsuzaki F, Suzuki S, Arita R, Ohsawa M, Obara R, Morishita K, Ueno F, Shinoda G, Orui M, Murakami K, Ishikuro M, Kikuchi A, Takayama S, Ishii T, Kawame H, Kure S, Kuriyama S. Noda A, et al. Among authors: morishita k. Drugs Real World Outcomes. 2024 Jun;11(2):263-272. doi: 10.1007/s40801-023-00411-0. Epub 2024 Jan 19. Drugs Real World Outcomes. 2024. PMID: 38240961 Free PMC article.
Medication use before and during pregnancy in Japan: the Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study.
Noda A, Obara T, Shirota M, Ueno F, Matsuzaki F, Hatanaka R, Obara R, Morishita K, Shinoda G, Orui M, Murakami K, Ishikuro M, Kuriyama S. Noda A, et al. Among authors: morishita k. Eur J Clin Pharmacol. 2024 Aug;80(8):1171-1180. doi: 10.1007/s00228-024-03685-7. Epub 2024 Apr 17. Eur J Clin Pharmacol. 2024. PMID: 38630193 Free PMC article.
Risk of major congenital malformations associated with first-trimester exposure to propulsives: A health administrative database study in Japan.
Ishikawa T, Obara T, Akazawa M, Noda A, Oyanagi G, Morishita K, Miyakoda K, Nishigori H, Kawame H, Yaegashi N, Kuriyama S, Mano N. Ishikawa T, et al. Among authors: morishita k. Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):196-205. doi: 10.1002/pds.5370. Epub 2021 Oct 20. Pharmacoepidemiol Drug Saf. 2022. PMID: 34628689
Validity of Administrative Data for Identifying Birth-Related Outcomes with the End Date of Pregnancy in a Japanese University Hospital.
Tajima K, Ishikawa T, Matsuzaki F, Noda A, Morishita K, Inoue R, Iwama N, Nishigori H, Sugawara J, Saito M, Obara T, Mano N. Tajima K, et al. Among authors: morishita k. Int J Environ Res Public Health. 2022 Apr 16;19(8):4864. doi: 10.3390/ijerph19084864. Int J Environ Res Public Health. 2022. PMID: 35457731 Free PMC article.
835 results